Neutralizing antibody to gB2 human cytomegalovirus does not prevent reactivation in patients with human immunodeficiency virus infection

Journal of General Virology

Volumn 84, Issue 7, 2003, Pages 1853-1857

  Rasmussen, Lucy ^a   Cowan, Catherine M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NEUTRALIZING ANTIBODY; VIRUS DNA;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENOTYPE; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LYMPHOCYTE COUNT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINITIS; RISK FACTOR; T LYMPHOCYTE; UNITED STATES; VIRUS ISOLATION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS STRAIN;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; GENOTYPE; HIV INFECTIONS; HUMANS; NEUTRALIZATION TESTS; VIRAL ENVELOPE PROTEINS; VIRUS ACTIVATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0038150863     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18896-0     Document Type: Article

References (16)

1. Adler, S. P., Starr, S. E., Plotkin, S. A., Hempfling, S. H., Buis, J., Manning, M. L.&Best, A. M. (1995). Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis 171, 26-32.
2. Alberola, J., Dominguez, V., Cardenoso, L.&7 other authors (1998). Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease. J Med Virol 55, 272-280.
3. Boppana, S. B.&Britt, W. J. (1995). Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 171, 1115-1121.
4. Boppana, S. B., Polis, M. A., Kramer, A. A., Britt, W. J. & Koenig, S. (1995). Virus-specific antibody responses to human cytomegalovirus (HCMV) in human immunodeficiency virus type 1-infected persons with HCMV retinitis. J Infect Dis 171, 182-185.
5. Britt, W. J., Vugler, L., Butfiloski, E. J.&Stephens, E. B. (1990). Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV- recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J Virol 64, 1079-1085.
6. Chou, S. W. (1986). Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. New Engl J Med 314, 1418-1423.
7. Collier, A. C., Chandler, S. H., Handsfield, H. H., Corey, L. &McDougall, J. K. (1989). Identification of multiple strains of cytomegalovirus in homosexual men. J Infect Dis 159, 123-126.
8. Drew, W. L., Sweet, E. S., Miner, R. C.&Mocarski, E. S. (1984). Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis 150, 952-953.
9. Rasmussen, L. (1999). Molecular pathogenesis of human cytomegalovirus infection. Transpl Infect Dis 1, 127-134.
10. Rasmussen, L. E., Nelson, R. M., Kelsall, D. C.&Merigan, T. C. (1984). Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proc Natl Acad Sci U S A 81, 876-880.
11. Rasmussen, L., Mullenax, J., Nelson, R.&Merigan, T. C. (1985). Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus. J Virol 55, 274-280.
12. Rasmussen, L., Zipeto, D., Wolitz, R. A., Dowling, A., Efron, B.&Merigan, T. C. (1997). Risk for retinitis in patients with AIDS can be assessed by quantitation of threshold levels of cytomegalovirus DNA burden in blood. J Infect Dis 176, 1146-1155.
13. Snydman, D. R. (2001). Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation. Transpl Infect Dis 3 (Suppl. 2), 6-13.
14. Urban, M., Britt, W.&Mach, M. (1992). The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific. J Virol 66, 1303-1311.
15. Zipeto, D., Morris, S., Hong, C., Dowling, A., Wolitz, R., Merigan, T. C.&Rasmussen, L. (1995). Human cytomegaiovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol 33, 2607-2611.
16. Zipeto, D., Hong, C., Gerna, G., Zavattoni, M., Katzenstein, D., Merigan, T. C.&Rasmussen, L. (1998). Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. AIDS Res Hum Retroviruses 14, 533-536.